Anrukinzumab
Подписчиков: 0, рейтинг: 0
| Monoclonal antibody | |
|---|---|
| Type | Whole antibody |
| Source | Humanized (from mouse) |
| Target | IL13 |
| Clinical data | |
| ATC code |
|
| Identifiers | |
| CAS Number | |
| ChemSpider |
|
| UNII | |
| Chemical and physical data | |
| Formula | C6452H9954N1714O2024S46 |
| Molar mass | 145393.34 g·mol−1 |
 N Y (what is this?) (verify)
| |
Anrukinzumab (IMA-638) is a humanized monoclonal antibody designed for the treatment of asthma.
Anrukinzumab was developed by Wyeth.
| IL-1 |
|
||||
|---|---|---|---|---|---|
| IL-2 | |||||
| IL-3 | |||||
| IL-4 |
|
||||
| IL-5 |
|
||||
| IL-6 |
|
||||
| IL-7 |
|
||||
| IL-8 |
|
||||
| IL-9 |
|
||||
| IL-10 |
|
||||
| IL-11 |
|
||||
| IL-12 |
|
||||
| IL-13 |
|
||||
| IL-15 |
|
||||
| IL-17 |
|
||||
| IL-18 |
|
||||
| IL-20 |
|
||||
| IL-21 |
|
||||
| IL-22 |
|
||||
| IL-23 |
|
||||
| IL-27 |
|
||||
| IL-28 | |||||
| IL-31 |
|
||||
| IL1RL1 |
|
||||
| IL1RL2 |
|
||||
| Others |
|
||||